Dimensional Fund Advisors LP Sells 9,723 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Dimensional Fund Advisors LP reduced its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 7.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 113,850 shares of the medical instruments supplier's stock after selling 9,723 shares during the period. Dimensional Fund Advisors LP owned approximately 2.10% of Mesa Laboratories worth $15,013,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Amundi raised its holdings in Mesa Laboratories by 81.6% during the 4th quarter. Amundi now owns 661 shares of the medical instruments supplier's stock worth $91,000 after buying an additional 297 shares during the period. Resona Asset Management Co. Ltd. acquired a new stake in Mesa Laboratories during the 4th quarter worth approximately $92,000. KLP Kapitalforvaltning AS acquired a new stake in Mesa Laboratories during the 4th quarter worth approximately $132,000. Berry Wealth Group LP raised its holdings in Mesa Laboratories by 5.3% during the 4th quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier's stock worth $219,000 after buying an additional 83 shares during the period. Finally, Pacer Advisors Inc. raised its holdings in Mesa Laboratories by 4.3% during the 4th quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier's stock worth $231,000 after buying an additional 73 shares during the period. 90.60% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Gary M. Owens sold 21,000 shares of Mesa Laboratories stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total value of $2,602,110.00. Following the sale, the chief executive officer now directly owns 43,337 shares in the company, valued at $5,369,887.67. This trade represents a 32.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 4.40% of the stock is owned by corporate insiders.

Mesa Laboratories Stock Down 0.5%

MLAB stock traded down $0.62 during mid-day trading on Tuesday, hitting $127.38. 39,168 shares of the company were exchanged, compared to its average volume of 40,758. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. The firm has a market cap of $692.18 million, a P/E ratio of -2.75 and a beta of 0.97. The firm's 50 day simple moving average is $119.04 and its 200 day simple moving average is $126.57. Mesa Laboratories, Inc. has a 1-year low of $83.68 and a 1-year high of $155.12.

Mesa Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Friday, May 30th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.50%. Mesa Laboratories's dividend payout ratio (DPR) is presently -1.38%.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.